Go to PegaPoll
PEGAPOLL · NEWS

Pill that mimics Viagra can slow Alzheimer’s progression, study suggests

Guardian Wellness · 2026-11-18
🤖 AI-generated content — The title and summary were produced automatically by artificial intelligence, without human editorial review.

A global stage three trial presented in Boston at the Clinical Trials on Alzheimer’s Disease conference shows that AR1001, a once-a-day pill from South Korean firm AriBio, slowed memory and thinking decline by 31% over one year in 604 early Alzheimer’s patients taking no other Alzheimer’s drugs. Spanning 13 countries, including the UK, the study also found mostly mild to moderate side effects.

Unlike existing therapies that target amyloid, AR1001 is a phosphodiesterase-5 inhibitor—from the same drug family as Viagra—that acts on a specific enzyme to relax blood vessels, boost brain blood flow, and likely stimulate pathways in brain cells tied to learning and memory. The search for new options is urgent: Alzheimer’s is the most common form of dementia, which currently has no cure and is forecast to affect 153 million people worldwide by 2050.

However, AR1001 failed to achieve statistically significant results across the broader trial group of patients already taking other Alzheimer’s medications, a finding that requires further study. Independent experts—including Prof Tara Spires-Jones of the University of Edinburgh, Dr Sheona Scales of Alzheimer’s Research UK, and Dr Richard Oakley of the Alzheimer’s Society—called the results promising, but warned against taking Viagra for Alzheimer’s and noted that further trials and regulatory review are needed before prescribing AR1001.

Continue in the app — vote & join in ➔
Source: Guardian Wellness · via ahirlevel.hu

Related news